GlassScriptPhysician profile
Brandt Davis
NPI 1508326422
$1,620.22
in general payments reported to CMS, 2019-2025
7 companies · $331 in 2025
The $331 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $717 · 2023: $480 · 2024: $91.53 · 2025: $331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $742 · Travel and Lodging: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $741.86 |
| Travel and Lodging | $160.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $622.06 | 2022-2025 | Ortholoc 3di Crosscheck, Augment Injectable, Actishield |
| Smith+Nephew, INC. | $460.57 | 2022-2023 | Cadence, Salto Talaris Total Ankle Prosthesis, Panta 2 |
| Arthrex, INC. | $287.47 | 2025 | |
| Medshape, INC. | $143.19 | 2023 | Dynanail Mini, Dynanail, Dynaclip Bone Fixation System, Quattro, 22mm X 20mm X 20mm |
| Trilliant Surgical LLC. | $59.28 | 2024 | Minimally Invasive Bunion Plate, Left |
| 4web, INC. | $31.25 | 2023 | Osteotomy Truss System |
| Mimedx Group, INC. | $16.40 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandt Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.